Almac, leaders in the management of temperature controlled clinical supplies, has further enhanced its service offering with the completed expansion of refrigerated (2-8°C) storage and newly developed refrigerated labeling facilities at its UK site. This enhancement doubles Almac’s refrigerated storage capacity at its UK site and comes as a response to a growing number of client requests involving Biologics, Biosimilar Compounds and other temperature critical material.
The labeling, packaging, and distribution of cold chain materials can often prove complicated given the temperature sensitive nature of the products. In most cases, the product has a limited amount of time that it can be out of the specified temperature, whether it be 2-8°C or colder. With the introduction of the refrigerated labeling facility and expansion of refrigerated storage, Almac is able to offer a more streamlined cold chain service by ensuring the material flow is consistently monitored at every stage in the clinical supply chain. The offering, mirrored at the company’s US headquarters in Souderton, PA, is a substantial benefit to existing and potential clients where maintaining temperature control is critical to the shelf life and stability of their compound or the chosen comparator.
Almac has already taken great strides in enhancing the distribution portion of cold chain management by introducing an enhanced cold chain shipper solution. The containers are smaller, lighter and more robust than existing shipper solutions on the market, retaining maximized product space, thus making them a very cost-effective shipping option for Almac’s customers. Sharon Courtney, Head of Distribution, commented ‘In the first 6 months since their implementation, the shippers achieved an impressive >0.33% excursion rate across the board, making this one of the most effective shipping solutions in the industry.‘ Coupled with Almac’s Shipping Temperature Electronic Monitoring System (STEMS), which allows for same day temperature data, Almac delivers a comprehensive and reliable solution for cold chain distribution.
Further assistance in managing the supply chain for cold materials can be achieved through the utilisation of Almac’s in-house Supply Chain Management (SCM) team. The SCM team will have visibility of and be responsible for managing the entire supply chain and will optimise the size and frequency of shipments of cold material, working with clients to develop transit routes that mitigate the risk of temperature excursion during shipment. Ultimately this allows Almac to create and deliver a more efficient process for temperature sensitive materials.
Commenting on these recent developments, Martin Lamb, Vice President of Business Development, said “Our suite of leading cold chain solutions is a response to the growing customer demand for clinical services for temperature sensitive materials. Our goal is to provide closed loop cold-chain solutions tailored towards our customer’s individual needs, remaining mindful that we are servicing an industry wherein effectiveness and efficiency are increasingly sought after attributes.”
Contact a member of our Cold Chain Team today or visit our website for an overview on Almac’s cold chain services.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.